340 related articles for article (PubMed ID: 16569192)
1. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.
Fu X; Ravindranath L; Tran N; Petrovics G; Srivastava S
DNA Cell Biol; 2006 Mar; 25(3):135-41. PubMed ID: 16569192
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients.
Petrovics G; Zhang W; Makarem M; Street JP; Connelly R; Sun L; Sesterhenn IA; Srikantan V; Moul JW; Srivastava S
Oncogene; 2004 Jan; 23(2):605-11. PubMed ID: 14724589
[TBL] [Abstract][Full Text] [Related]
3. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.
Srikantan V; Zou Z; Petrovics G; Xu L; Augustus M; Davis L; Livezey JR; Connell T; Sesterhenn IA; Yoshino K; Buzard GS; Mostofi FK; McLeod DG; Moul JW; Srivastava S
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12216-21. PubMed ID: 11050243
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells.
He JH; Zhang JZ; Han ZP; Wang L; Lv YB; Li YG
J Exp Clin Cancer Res; 2014 Sep; 33(1):72. PubMed ID: 25200485
[TBL] [Abstract][Full Text] [Related]
5. γ-Oryzanol reduces caveolin-1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines.
Hirsch GE; Parisi MM; Martins LA; Andrade CM; Barbé-Tuana FM; Guma FT
Prostate; 2015 Jun; 75(8):783-97. PubMed ID: 25619388
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
[TBL] [Abstract][Full Text] [Related]
7. MEF2‑activated long non‑coding RNA PCGEM1 promotes cell proliferation in hormone‑refractory prostate cancer through downregulation of miR‑148a.
Zhang S; Li Z; Zhang L; Xu Z
Mol Med Rep; 2018 Jul; 18(1):202-208. PubMed ID: 29749452
[TBL] [Abstract][Full Text] [Related]
8. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
9. p21CIP1 Induces Apoptosis via Binding to BCL2 in LNCaP Prostate Cancer Cells Treated with MCS-C3, A Novel Carbocyclic Analog of Pyrrolopyrimidine.
Choi KW; Suh H; Oh HL; Ryou C; Lee CH
Anticancer Res; 2016 Jan; 36(1):213-20. PubMed ID: 26722046
[TBL] [Abstract][Full Text] [Related]
10. Antisense Bcl-2 sensitizes prostate cancer cells to radiation.
Mu Z; Hachem P; Pollack A
Prostate; 2005 Dec; 65(4):331-40. PubMed ID: 16015611
[TBL] [Abstract][Full Text] [Related]
11. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
12. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
[TBL] [Abstract][Full Text] [Related]
13. A long noncoding RNA connects c-Myc to tumor metabolism.
Hung CL; Wang LY; Yu YL; Chen HW; Srivastava S; Petrovics G; Kung HJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18697-702. PubMed ID: 25512540
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
15. Emodin induces apoptosis in human prostate cancer cell LNCaP.
Yu CX; Zhang XQ; Kang LD; Zhang PJ; Chen WW; Liu WW; Liu QW; Zhang JY
Asian J Androl; 2008 Jul; 10(4):625-34. PubMed ID: 18478162
[TBL] [Abstract][Full Text] [Related]
16. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
17. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells.
Gupta S; Afaq F; Mukhtar H
Oncogene; 2002 May; 21(23):3727-38. PubMed ID: 12032841
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostate cancer cell growth by human secreted PDZ domain-containing protein 2, a potential autocrine prostate tumor suppressor.
Tam CW; Cheng AS; Ma RY; Yao KM; Shiu SY
Endocrinology; 2006 Nov; 147(11):5023-33. PubMed ID: 16873542
[TBL] [Abstract][Full Text] [Related]
19. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.
Pulukuri SM; Rao JS
Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979
[TBL] [Abstract][Full Text] [Related]
20. Bim directly antagonizes Bcl-xl in doxorubicin-induced prostate cancer cell apoptosis independently of p53.
Yang MC; Lin RW; Huang SB; Huang SY; Chen WJ; Wang S; Hong YR; Wang C
Cell Cycle; 2016; 15(3):394-402. PubMed ID: 26694174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
